NYU LANGONE HEALTH

Gliomas, common malignant brain tumors, originate from glial cells. IDH mutations fuel tumor growth; drugs targeting IDH mutations like Vorasidenib offer new treatment options, especially for low-grade gliomas. Continued research aims to uncover more gene mutations driving tumor growth for improved treatments.

New study in the New England Journal of Medicine finds kidney transplants between HIV-positive donors and recipients are safe and effective, with similar one- and three-year survival rates and organ rejection rates. The research, led by Dr. Dorry Segev, suggests HIV-positive kidney donation should become standard practice.

A study in Academic Medicine found that 3-year medical school graduates performed equally well on skill and knowledge tests compared to 4-year graduates. NYU's accelerated program offers a direct pathway to residency, saving students a year of tuition and enabling an extra year of earnings.

New research shows humans can detect millisecond shifts in odor as quickly as color changes, challenging the notion that smell is a 'slower' sense. The study, led by Dr. Zhou Wen, used a sniff-triggered device to demonstrate participants could sense differences in odors with a 60-millisecond delay, similar to visual perception of light order. The findings suggest the human sense of smell should be taken more seriously in scientific study and could have applications in therapeutic olfactory training and electronic nose development.

NYU Langone Health experts discuss various medical topics, including Kayvon Thibodeaux's wrist surgery, methadone restrictions for opioid addiction, microdiscectomy surgery outcomes, dental residency program expansion, blood pressure measurement accuracy, prescription drug shortages, oral bacteria linked to cancer risk, eyelash serum effects, outdoor walking benefits, IV fluid shortage prevention, vaginal fluid acidity, and postpartum drowsiness.

NYU Langone Health newsletter referenced AJMC.com's interview with Dr. Joshua K. Sabari on amivantamab for NSCLC. Becker’s GI & Endoscopy cited AJMC.com's article on updated colonoscopy guidelines. Pharmacy Times mentioned The Center for Biosimilars' report on FDA approval of ustekinumab-auub as a Stelara biosimilar.

The FDA approved flurpiridaz F-18, a new PET tracer for myocardial perfusion imaging, expected to boost PET testing growth. It's the first new cardiac PET radiotracer in decades, with a longer half-life and superior image quality, enhancing diagnostic certainty. This will expand PET use, improve collaboration among cardiologists, and increase patient access to the test.

A study by NIH's RECOVER Initiative and NYU Langone Health found no reliable biomarkers in routine clinical lab tests for diagnosing long COVID, highlighting the need for further research beyond standard methods.

NYU Langone Health study links oral bacteria to increased risk of head and neck squamous cell carcinoma; tirzepatide reduces heart failure risks; Jennifer Tyburski's thyroid cancer diagnosis highlights self-advocacy; soy consumption does not increase breast cancer risk; gas can cause chest pain; Jason E. Lowenstein, MD, recognized for spine deformity treatment.

Breastfeeding through the first year lowers asthma risk by shaping a healthy infant microbiome, with early weaning linked to higher asthma risk. Breast milk's nutrients promote a beneficial microbial order, crucial for immune system development.